ZBIO

Zenas BioPharma, Inc.
28.39 -1.29% 2026-10-30
52-week range
13.50 44.60
1-month+1.6%
3-month-8.8%
1-year+1.4%
vs 50-day-3.7%
vs 200-day+13.8%
Volatility95%
Beta0.50
$ vol/day$14M
ATH44.60
From ATH-36.3%
Next report2026-11-12
Nothing written about ZBIO yet. Be the first — call it long or short with an entry we price for you, or post a neutral write-up that takes no side. Create a free account
2026AprJulOct

bought sold · bigger dot, bigger trade · follows the chart’s range

WhenPeople SizeValuePrice
6mo buy 1 $1,012,800 17.52
6mo buy 1 $1,067,200 17.80
7mo buy 1 $70,198 20.98
7mo buy 1 $3,000,000 19.88
7mo buy 2 $2,521,140 18.95
9mo buy 2 $1,084,408 26.43
9mo buy 1 $1,023,720 19.04
10mo buy 1 $1,639,000 16.63
1.1y buy 3 $5,850,014 26.45
1.1y buy 3 $12,778,141 27.12
1.5y buy 1 $77,600 10.25
1.7y buy 1 $166,750 6.75
1.7y buy 1 $77,600 7.37
1.9y buy 1 $718,100 10.21
2.0y buy 1 $148,925 13.13
2.1y buy 1 $360,820 18.24
2.1y buy 1 $15,000,001 17.79
2.1y buy 2 $6,099,991 17.56
2.1y buy 4 $65,579,982 17.96

Next report 2026-11-12 (Thursday, before open, in 10 days) · EPS estimate -1.27. It has finished the next session higher 57% of the time, average move 5.4%.

Day-after move, last 7 reports, oldest left.

ReportedEst.Actual SurpriseGapDay 1Day 5
2026-08-13 miss -0.75 -1.77 -134.4% -2.9% -6.7% +1.1%
2026-05-13 beat -1.54 -1.46 +5.2% +2.3% +4.0% +2.1%
2026-03-16 miss -1.19 -1.39 -16.8% -2.9% -3.4% -14.2%
2025-11-12 miss -0.85 -1.22 -44.1% +2.3% +1.7% +5.5%
2025-08-12 miss -1.06 -1.25 -17.9% -2.7% +6.7% +6.3%
2025-05-15 beat -1.03 -0.80 +22.3% +5.1% +12.2% +31.9%
2024-11-12 beat -9.30 -5.02 +46.0% -0.9% -3.1% -31.8%
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+1.5%
Next 1 week
+1.9%
Next 1 month
+1.2%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 50
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.80%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.50 +1.2%
$14M/day volume 95% volatility +1% 1-year -36% from ATH
52-week range · 48% of the way up · -36% from the high
$13.50$44.60

Not investment advice.